Bryn Mawr Trust CO Skye Bioscience, Inc. Transaction History

Bryn Mawr Trust CO

  • $2.54 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.01 - $6.75 $119 - $80,325
11,900 New
11,900 $0

About Skye Bioscience, Inc.

SKYE Quotes by TradingView
  • Ticker SKYE
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 495,924,992
  • Market Cap $2.74B
  • Description
  • Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical t...
More about SKYE
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email